Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2020-08-03 22:36 2020-07-30 FFIV F5, INC. FOUNTAIN THOMAS DEAN Officer - EVP Global Services & Strategy Computer Communications Equipment BUY $136.52 8,060 $1,100,333 10,581 +319.7%
2020-07-31 16:58 2020-07-29 LCRDX Lord Abbett Credit Opportunities Fund Christina & Robert Dow Foundation 10% owner Other BUY $9.05 440,044 $3,982,398 7,203,969 +6.5%
2020-08-01 00:18 2020-07-23 SHRG Sharing Services Global Corporation DOCUMENT SECURITY SYSTEMS INC 10% owner Wholesale-Drugs, Proprietaries & Druggists' Sundries BUY $0.08 30,000,000 $2,400,000 62,417,593 +92.5%
2020-07-31 16:20 2020-07-29 EVF Eaton Vance Senior Income Trust Saba Capital Management, L.P. 10% owner Other BUY $5.63 431,208 $2,426,235 6,751,165 +6.8%
2020-07-31 04:55 2020-07-28 GRCYU N/A Liu Jinlong Director Other BUY $10.00 260,000 $2,600,000 1,410,000 +22.6%
2020-07-31 04:55 2020-07-28 GRCYU N/A Yu Jianmin Officer, 10% owner - CFO Other BUY $10.00 260,000 $2,600,000 1,410,000 +22.6%
2020-07-31 04:56 2020-07-28 GRCYU N/A Cynthia Management Corp 10% owner Other BUY $10.00 260,000 $2,600,000 1,410,000 +22.6%
2020-07-30 16:00 2020-07-28 ITOS N/A Davis Aaron I. Director, 10% owner Other BUY $19.00 1,425,000 $27,075,000 72,243 +100.0%
2020-07-31 00:34 2020-07-30 FRG N/A KAHN BRIAN RANDALL Director, Officer, 10% owner - Chief Executive Officer Other BUY $23.25 400,000 $9,300,000 400,000 +100.0%
2020-07-31 02:23 2020-07-28 GHL N/A BOK SCOTT L Director, Officer, 10% owner - Chairman & CEO Other BUY $10.96 148,614 $1,629,181 1,016,077 +17.1%
2020-07-31 02:13 2020-07-29 PSTI Pluri Inc. CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP 10% owner Biological Products, (No Diagnostic Substances) BUY $9.03 121,926 $1,100,992 3,663,966 +3.4%
2020-07-30 15:00 2020-07-28 ITOS N/A GADICKE ANSBERT Director, 10% owner Other BUY $19.00 320,000 $6,080,000 2,355,557 +15.7%
2020-07-31 03:56 2020-07-24 GNCA N/A GLAXOSMITHKLINE PLC 10% owner Other BUY $2.25 1,260,504 $2,836,134 4,626,389 +37.4%
2020-07-31 03:00 2020-07-28 ANNX Annexon, Inc. Clarus Lifesciences III, L.P. 10% owner Pharmaceutical Preparations BUY $17.00 200,000 $3,400,000 2,730,635 +7.9%
2020-07-31 03:19 2020-07-28 BAC BANK OF AMERICA CORP /DE/ BERKSHIRE HATHAWAY INC 10% owner National Commercial Banks BUY $24.65 21,180,716 $522,043,225 1,019,267,705 +2.1%
2020-07-30 00:29 2020-07-28 INZY N/A Novo Holdings A/S 10% owner Other BUY $16.00 375,000 $6,000,000 2,569,379 +17.1%
2020-07-30 00:24 2020-07-28 TTPH N/A LA JOLLA PHARMACEUTICAL CO 10% owner Other BUY $2.00 3,737,360 $7,474,720 4,822,360 +344.5%
2020-07-30 04:35 2020-07-28 ITOS N/A RA CAPITAL MANAGEMENT, L.P. 10% owner Other BUY $19.00 1,425,000 $27,075,000 4,417,259 +47.6%
2020-07-30 04:18 2020-07-28 ITOS N/A MPM BioVentures 2014, L.P. 10% owner Other BUY $19.00 160,000 $3,040,000 25,974 +100.0%
2020-07-29 13:06 2020-07-28 INZY N/A Sanofi 10% owner Other BUY $16.00 81,250 $1,300,000 520,125 +18.5%
2020-07-30 01:56 2020-07-27 MEG Montrose Environmental Group, Inc. GRAHAM PETER Director Services-Management Consulting Services BUY $15.00 90,000 $1,350,000 206,447 +77.3%
2020-07-29 16:55 2020-07-28 KMI KINDER MORGAN, INC. KINDER RICHARD D Director, Officer, 10% owner - Executive Chairman Natural Gas Transmission BUY $14.14 300,000 $4,241,610 244,839,120 +0.1%
2020-07-30 04:38 2020-07-28 ITOS N/A Boxer Capital, LLC 10% owner Other BUY $19.00 1,425,000 $27,075,000 72,243 +100.0%
2020-07-29 01:15 2020-07-28 INZY N/A Pivotal bioVenture Partners Fund I, L.P. 10% owner Other BUY $16.00 187,500 $3,000,000 1,591,154 +13.4%
2020-07-29 01:28 2020-07-28 INZY N/A Makhzoumi Mohamad 10% owner Other BUY $16.00 250,000 $4,000,000 2,437,689 +11.4%
2020-07-29 01:26 2020-07-28 INZY N/A New Enterprise Associates 15, L.P. 10% owner Other BUY $16.00 250,000 $4,000,000 2,437,689 +11.4%
2020-07-29 03:53 2020-07-28 INZY N/A Rock Springs Capital Management LP 10% owner Other BUY $16.00 600,000 $9,600,000 1,067,884 +128.2%
2020-07-29 01:27 2020-07-28 INZY N/A Florence Anthony A. Jr. 10% owner Other BUY $16.00 250,000 $4,000,000 2,437,689 +11.4%
2020-07-29 01:30 2020-07-28 INZY N/A Sonsini Peter W. 10% owner Other BUY $16.00 250,000 $4,000,000 2,437,689 +11.4%
2020-07-29 01:11 2020-07-28 INZY N/A Hopfner Robert Lorne Director, 10% owner Other BUY $16.00 187,500 $3,000,000 1,591,154 +13.4%
2020-07-28 23:45 2020-07-28 ANNX Annexon, Inc. Bain Capital Life Sciences Investors, LLC 10% owner Pharmaceutical Preparations BUY $17.00 400,000 $6,800,000 3,241,628 +14.1%
2020-07-29 00:26 2020-07-24 GNCA N/A Walker Paul Edward 10% owner Other BUY $2.25 3,151,260 $7,090,335 10,376,936 +43.6%
2020-07-29 00:26 2020-07-24 GNCA N/A Sonsini Peter W. 10% owner Other BUY $2.25 3,151,260 $7,090,335 10,376,936 +43.6%
2020-07-29 00:23 2020-07-24 GNCA N/A Makhzoumi Mohamad 10% owner Other BUY $2.25 3,151,260 $7,090,335 10,376,936 +43.6%
2020-07-29 00:23 2020-07-24 GNCA N/A Florence Anthony A. Jr. 10% owner Other BUY $2.25 3,151,260 $7,090,335 10,376,936 +43.6%
2020-07-29 00:22 2020-07-24 GNCA N/A Chang Carmen 10% owner Other BUY $2.25 3,151,260 $7,090,335 10,376,936 +43.6%
2020-07-29 00:22 2020-07-24 GNCA N/A Behbahani Ali Director, 10% owner Other BUY $2.25 3,151,260 $7,090,335 10,376,936 +43.6%
2020-07-29 00:19 2020-07-24 GNCA N/A New Enterprise Associates 16, L.P. 10% owner Other BUY $2.25 3,151,260 $7,090,335 10,376,936 +43.6%
2020-07-29 01:33 2020-07-28 INZY N/A RA CAPITAL MANAGEMENT, L.P. 10% owner Other BUY $16.00 600,000 $9,600,000 2,003,653 +42.7%
2020-07-28 23:17 2020-07-28 ANNX Annexon, Inc. Satter Muneer A Director Pharmaceutical Preparations BUY $17.00 200,000 $3,400,000 1,954,978 +11.4%
2020-07-28 23:36 2020-07-27 SREV N/A Edenbrook Capital, LLC 10% owner Other BUY $1.55 715,389 $1,108,638 11,590,399 +6.6%
2020-07-29 01:26 2020-07-28 INZY N/A BASKETT FOREST 10% owner Other BUY $16.00 250,000 $4,000,000 2,437,689 +11.4%
2020-07-29 00:20 2020-07-24 GNCA N/A BASKETT FOREST 10% owner Other BUY $2.25 3,151,260 $7,090,335 10,376,936 +43.6%
2020-07-29 01:20 2020-07-28 INZY N/A Longitude Capital Partners III, LLC 10% owner Other BUY $16.00 625,000 $10,000,000 2,819,379 +28.5%
2020-07-29 01:29 2020-07-28 INZY N/A SANDELL SCOTT D 10% owner Other BUY $16.00 250,000 $4,000,000 2,437,689 +11.4%
2020-07-29 00:25 2020-07-24 GNCA N/A SANDELL SCOTT D 10% owner Other BUY $2.25 3,151,260 $7,090,335 10,376,936 +43.6%
2020-07-29 01:29 2020-07-28 INZY N/A MAKOWER JOSHUA 10% owner Other BUY $16.00 250,000 $4,000,000 2,437,689 +11.4%
2020-07-29 00:24 2020-07-24 GNCA N/A MAKOWER JOSHUA 10% owner Other BUY $2.25 3,151,260 $7,090,335 10,376,936 +43.6%
2020-07-29 01:08 2020-07-28 INZY N/A Sofinnova Venture Partners X, L.P. 10% owner Other BUY $16.00 437,500 $7,000,000 2,028,308 +27.5%
2020-07-29 00:40 2020-07-24 NGM N/A COLUMN GROUP L P Director, 10% owner Other BUY $17.93 72,583 $1,301,645 1,612,847 +4.7%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.